Promising results from mouse study lead to expanded trials

First-in-human trial of PTD802 to commence following UK MHRA approval

Initiative aims to identify plasma-based biomarkers for early detection

Survey finds AI to enhance productivity and cut costs in the next 12 months

CR-discovered NXP800 shows promise in clinical trials

Groundbreaking approval provides new hope for patients in England and Wales

New FDA-approved schizophrenia treatment shows promise in clinical trials

Investment to support RNA therapeutics for epilepsy and neurological disorders

OAV101 IT expands potential for type II SMA patients